Champions Oncology
Hackensack, NJ, United States championsoncology.com From their website, Nov 2026
Work here? Claim this listing
About
Champions Oncology is a preclinical oncology CRO providing patient-derived models, ex vivo and in vivo studies, and multi-omic data services for drug developers and researchers. It serves oncology programs across solid tumors, hematologic malignancies, CDX and PDX models, with operations in Hackensack, New Jersey; Rockville, Maryland; and Rehovot, Israel. The company also supports global studies through scientific consultation, model selection, and analytical readouts.
Services
Solid Tumor PDX Models
Provides patient-derived xenograft models for solid tumor oncology research with clinical annotation and multi-omic characterization.
Blood Cancer Models
Offers hematological tumor and leukemia xenograft models including AML, ALL, CLL, lymphoma, and multiple myeloma for preclinical testing.
Pretreated PDX Models
Provides PDX models from pretreated patients to study resistance mechanisms, next-line therapies, and clinical translation.
CDX Models
Offers cell line-derived xenograft models for proof-of-concept, target validation, resistance studies, and biomarker work.
PDX Model Bank
Maintains a searchable bank of patient-derived tumor models for selecting models by tumor indication, modality, or molecular profile.
CDX Model Bank
Provides a filtered bank of CDX models for selection by tumor indication, genetic profile, and gene expression.
TumorGraft3D Ex Vivo Platform
Supports selected ex vivo studies using low-passage, PDX-derived 3D tumor models for cohort comparison and translational questions.
Hematological VitroScreen
Runs ex vivo hematologic assays to test therapeutics in blood cancer models.
22 more services
- Ex Vivo Solid Tumor Screening
- In Vivo Preclinical Mouse Models
- In Vivo Screening (Mouse Clinical Trials)
- Matched Multi-Omic Dataset
- Lumin Data Platform
- Cell Surface Proteomics Dataset
- KRAS-Mutant Atlas
- Radiopharmaceutical Services
- Analytical Assays
- Co-Culture Assays
- Ex Vivo Hematological Cancer Screen
- Flow Cytometry
- Histology / IHC
- ELISA / Luminex
- Next Generation Sequencing
- 4D Proteomics
- Western Blot
- DNA Damage Assays
- Colony Forming Unit (CFU) Assay
- Imaging
- Cell Viability & Proliferation
- Quantitative PCR
- Turnaround
- Within 24 hours
- Within one business day
- What to send
- Leukapheresis
- Peripheral blood
- Bone marrow aspirates
- Biopsies of patients with advanced-stage disease
Capabilities
- Assays and studies
- In vivo
- Rodent models
- Flow cytometry
- NGS
- ADCs
- ELISA
17 more
- Antibodies
- Histology
- IHC
- Luminex
- Next generation sequencing
- 4D proteomics
- Western blot
- DNA damage assays
- Colony forming unit (CFU) assay
- Imaging
- Cell viability
- Proliferation
- Quantitative PCR
- Co-culture assays
- Proteomics
- Phospho-proteomics
- CFU assay
- Scale and capacity
- Over 1,500 patient-derived models
- Over 1,400 patient-derived models
- 700+ pretreated PDX models
- 600+ cell-surface profiled models
- 300+ TumorGraft3D models
- 1,615 RNA-Seq models
7 more
- 1,599 whole-exome models
- 1,006 whole-cell protein models
- 607 surface proteomics models
- Over 1,500 highly characterized PDX models
- 700+ pretreated models
- Over 100 cell-line derived xenograft mouse models
- 35,000 sq. ft. Rockville, MD research facility
- Therapeutic areas
- Oncology
- Solid tumors
- Hematologic malignancies
- Bladder cancer
- Prostate cancer
- Kidney cancer
7 more
- Melanoma
- Skin cancer
- Breast cancer
- Colorectal cancer
- Leukemia
- Lymphoma
- Multiple myeloma
Instruments and platforms
- SPECT/CT
- LC-MS
- IVIS
Modalities and species
- Modalities
- Small molecule
- Antibody
- Bispecific
- ADC
- Cell therapy
- Species and models
- Human
- Mouse
- Patient-derived xenograft (PDX)
- Cell line-derived xenograft (CDX)
- Acute myeloid leukemia (AML)
- Acute lymphoblastic leukemia (ALL)
14 more
- Chronic lymphoblastic leukemia (CLL)
- Diffuse large B-cell lymphoma (DLBCL)
- Mantle cell lymphoma
- Multiple myeloma
- NSCLC
- Colorectal cancer
- Pancreatic cancer
- Patient-derived xenografts (PDX)
- Cell line-derived xenografts (CDX)
- Syngeneic mouse models
- Humanized mouse models
- Solid tumor models
- Blood cancer models
- Hematological cancer models
Industries served
- Biotech
- Pharma
- Oncology
Company
- Type
- CRO
- Founded
- 2007
- Quality
- GCLP (clinical flow cytometry services)
Locations
- Office
- 1330 Piccard Drive, Suite 025 & Suite 104 Rockville, MD 20850, USA
- Sites
- Rockville, USA
- Rehovot, Israel
- Serves
- Global, U.S., globally, U.S.-based
Contacts
- Phone
- +1-240-907-2446